ORIGINAL RESEARCH article

Front. Genet.

Sec. Applied Genetic Epidemiology

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1555515

Genetic Association of ACE2 rs2285666 (C>T) and rs2106809 (A>G) and susceptibility to SARS-CoV-2 infection among the Ghanaian population.

Provisionally accepted
Alexander  Owusu BoakyeAlexander Owusu Boakye1,2Christian  ObirikorangChristian Obirikorang1,2Anthony  Afum-Adjei AwuahAnthony Afum-Adjei Awuah1,2Evans  Asamoah AduEvans Asamoah Adu1,2Doris  WinterDoris Winter3Eric  Ebenezer BohamEric Ebenezer Boham1,2Hakim  AlaniHakim Alani1Sylvester  Kofi NewtonSylvester Kofi Newton1Nana Safi  Toure AlmoustaphaNana Safi Toure Almoustapha1James  DekeJames Deke1Welbeck  Odame DzadeyWelbeck Odame Dzadey1Louis  Adu-AmoahLouis Adu-Amoah1,2Sally-Ann  KroduahSally-Ann Kroduah1,4Mary  Ama GrantMary Ama Grant1Gracelyn  AsareGracelyn Asare1Amos  Amoako-AduseiAmos Amoako-Adusei1Wibke  LoagWibke Loag3Jenny  KettenbeilJenny Kettenbeil5Yaw  Adu-SarkodieYaw Adu-Sarkodie6Ebenezer  Oduro-MensahEbenezer Oduro-Mensah7Alfred  Edwin YawsonAlfred Edwin Yawson8Stephen  ApangaStephen Apanga9Rose  Adjei OdoteiRose Adjei Odotei1,4Austin  Gideon Adobasom-AnaneAustin Gideon Adobasom-Anane1,4Eva  LorenzEva Lorenz10,11,3Aurelia  SouaresAurelia Souares10,12Oumou  Maiga-AscofareOumou Maiga-Ascofare1,10,5Juergen  MayJuergen May10,13,5Nicole  S. StruckNicole S. Struck10,3*John  Humphery AmuasiJohn Humphery Amuasi1,13,4,5*
  • 1Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana
  • 2Department of Molecular Medicine, School of Medicine and Denistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
  • 3Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Hamburg, Germany
  • 4School of Public Health, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
  • 5Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Hamburg, Germany
  • 6Department of Clinical Microbiology, School of Medicine and Denistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
  • 7GA East Hospital, Accra, Ghana
  • 8Medical School, University of Ghana, Accra, Ghana
  • 9Department of Community Health and Preventive Medicine, School of Medicine, University for Development Studies, Tamale, Ghana
  • 10German Center for Infection Research (DZIF), Partner Site Hamburg Lübeck Borstel Riems, Hamburg, Hamburg, Germany
  • 11Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes Gutenberg University Mainz, Mainz, Rhineland-Palatinate, Germany
  • 12Heidelberg Institute of Global Health, Heidelberg University Hospital, Heidelberg, Baden-Württemberg, Germany
  • 13Department of Tropical Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Hamburg, Germany

The final, formatted version of the article will be published soon.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), enters human cells using the angiotensin-converting enzyme 2 (ACE-2) receptor. ACE2 single nucleotide polymorphisms (SNPs) can influence susceptibility by affecting viral binding or gene expression. This study investigated the association between ACE2 SNPs, rs2285666 and rs2106809, and the SARS-CoV-2 infection susceptibility in a Ghanaian population.Genomic DNA was extracted, using a magnetic bead-based method, from blood samples of a random-subset of 1,334 participants drawn from a two-stage cluster, population-based household cross-sectional SARS-CoV-2 IgG seroprevalence survey. Data collected included, socio-demographic characteristics, medical history, vaccination, and smoking status.Genotyping of the ACE2 SNPs was performed using Allele-Specific Oligonucleotide Polymerase Chain Reaction (ASO-PCR) combined with melting curve analysis. Logistic regression models were utilized to assess the association between the ACE2 SNPs and the susceptibility to SARS-CoV-2 infection.The median age of participants was 33 (Interquartile range [IQR] = 24 -46) years. Females accounted for the majority of the sampled population, 64.3%. SARS-CoV-2-IgG seropositivity was (58.4%, 95%CI: 52.6% -64.2%) among the male population and (54.1%, 95%CI: 49.54% -58.61%) in the female population. There were no significant differences in overall allele or genotype frequencies of ACE2 SNPs between SARS-CoV-2 IgG seropositive and seronegative individuals for both females and males. Among females, those with the T allele of ACE2 rs2285666 had a 38% decreased susceptibility to SARS-CoV-2 infection under the dominant (adjusted odds ratio [aOR] = 0.62; 95%CI = 0.45 -0.85, P= 0.003) and heterozygous advantage models (aOR = 0.62; 95%CI = 0.45 -0.86, P= 0.004), after adjusting for confounders, but not the recessive model (aOR = 0.41; 95%CI = 0.03 -5.22, P= 0.490). No significant association was observed among males. Overall, the ACE2 rs2106809 was not associated with the susceptibility to SARS-CoV-2 infection in both males and females.This study found no for association between ACE2 rs2106809 genetic variant and susceptibility to SARS-CoV-2 infection, whilst the rs2285666 T-allele was associated with a decreased frequency for SARS-CoV-2 infection among Ghanaian females. These findings enhance our understanding of genetic factors influencing SARS-CoV-2 susceptibility, which could help identify at-risk populations and inform more targeted public health interventions in future outbreaks.

Keywords: Angiotensin-converting enzyme 2 (ACE2), single nucleotide polymorphism (SNP), SARS-CoV-2 susceptibility, genetic epidemiological study, SARS-CoV-2 infection (COVID-19), candidate gene association study (CGAS)

Received: 04 Jan 2025; Accepted: 07 May 2025.

Copyright: © 2025 Owusu Boakye, Obirikorang, Afum-Adjei Awuah, Adu, Winter, Boham, Alani, Newton, Almoustapha, Deke, Dzadey, Adu-Amoah, Kroduah, Grant, Asare, Amoako-Adusei, Loag, Kettenbeil, Adu-Sarkodie, Oduro-Mensah, Yawson, Apanga, Odotei, Adobasom-Anane, Lorenz, Souares, Maiga-Ascofare, May, Struck and Amuasi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Nicole S. Struck, Infectious Disease Epidemiology, Bernhard Nocht Institute for Tropical Medicine (BNITM), Hamburg, Hamburg, Germany
John Humphery Amuasi, Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.